Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
- Resource Type
- Source
- Leukemia & Lymphoma. 62:419-427
- Subject
Adult Oncology Cancer Research medicine.medical_specialty Transplantation Conditioning Graft vs Host Disease ThioTEPA Single Center 03 medical and health sciences 0302 clinical medicine Internal medicine Humans Medicine Myelofibrosis Busulfan Aged business.industry Hematopoietic Stem Cell Transplantation Hematology Middle Aged medicine.disease Fludarabine Transplantation Haematopoiesis Primary Myelofibrosis 030220 oncology & carcinogenesis Cohort business Thiotepa Vidarabine 030215 immunology medicine.drug - Language
- ISSN
- 1029-2403
1042-8194